Find Product:

Cancer of the lung, 75 cases (1.1mm), set 1
LUC1501
Pantomics 1
Description: Lung cancer tissue array, set 1, non-overlapping with LUC1502 or LUC1503, 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates.
Cancer of the lung (small cell carcinoma), 75 cases (1.1mm), set 4
LUC1504
Pantomics 1
Description: Lung cancer tissue array (small cell carcinoma), set 4, 150 cores from normal/benign (5 cases) and small cell carcinoma (70 cases with TNM staging data) tissues in duplicates.
Cancer of the lung, 75 cases (1.1mm), set 2
LUC1502
Pantomics 1
Description: Lung cancer tissue array, set 2, non-overlapping with LUC1501 or LUC1502, 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates.
Cancer of the lung, 75 cases (1.1mm), set 3
LUC1503
Pantomics 1
Description: Lung cancer tissue array, set 3, non-overlapping with LUC1501 or LUC1502, 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates.
Cancer of the lung, 102 cases (1.5mm)
LUC1021
Pantomics 1
Description: Lung cancer tissue array, 102 cases of normal/benign (5 cases) and cancer (97 cases with grading and TNM staging data.) tissues
Cancer of the lung, 228 cases (1.1mm)
LUC2281
Pantomics 1
Description: Lung cancer tissue array containing 8 cases of normal/benign conditions and 220 cases of cancers with grading and TNM staging data.
Cancer of the lung (adenocarcinoma), 80 cases (1.1mm), set 1
LUC1601
Pantomics 1
Description: Lung cancer tissue array (adenocarcinoma), 160 cores from normal (3 cases) and various types of adenocarcinoma (77 cases with TNM staging data) tissues in duplicates.
Cancer of the lung (squamous cell carcinoma) paired with normal, 75 cases (1.1mm), set 6.
LUC1506
Pantomics 1
Description: Lung cancer tissue array (squamous cell carcinoma), 150 cores from 75 cases, with paired normal tissues from the same patients, with grading and TNM staging data.
Cancer of the lung (squamous cell carcinoma), 80 cases (1.1mm), set 2
LUC1602
Pantomics 1
Description: Lung cancer tissue array (squamous cell carcinoma), 160 cores from normal (2 cases) and squamous cell carcinoma (78 cases with grading, TNM staging data) tissues in duplicates.
Cancer of the lung paired with normal, 16 cases (2mm), set 1
LUC481
Pantomics 1
Description: Lung cancer tissue array, set 1, 16 cases, 48 cores, non-over lapping with LUC482 or LUC483 one normal lung tissue core paired with two tumor tissue cores from each patient with grading and TNM staging data.
Cancer of the lung with progressive changes, 48 cases (1.5mm), set 1
LUC961
Pantomics 1
Description: Lung cancer tissue array, set 1, non-overlapping with LUC962, 96 cores, 48 cases from normal, premalignant and cancer tissues with progressive grades and TNM stages in duplicates.
Cancer of the lung paired with metastasis, 48 cases (1.5mm)
LUM961
Pantomics 1
Description: Lung cancer tissue array containing paired primary and metastatic tumors (in lymph nodes and other organs) from the same patients, 96 cores, 48 cases
Cancer of the lung (adenocarcinoma) paired with normal, 75 cases, set 5 (1.1mm), with clinical data
LUC1505
Pantomics 1
Description: Lung cancer tissue array (adenocarcinoma), 150 cores from 75 cases, with paired normal tissues from the same patients with clinical data including treatment and follow up information.
Cancer of the cervix, 75 cases (1.1mm), set 1
CXC1501
Pantomics 1
Description: Cervical cancer tissue array, set 1, non-overlapping with CXC1502 or CXC1503, consisting of 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates.
Cancer of the breast, 75 cases (1.1mm), set 1
BRC1501
Pantomics 1
Description: Breast cancer tissue array, set 1, non-overlapping with BRC1502 to BRC15011,150 cores from normal/benign (5 cases) and cancer (70 cases) tissues in duplicates with grading, TNM staging, and AR, ER, PR, HER2, P53, EGFR, Ki67 IHC data.
Cancer of the colon, 75 cases (1.1mm), set 1
COC1501
Pantomics 1
Description: Colon cancer tissue array, set 1, non-overlapping with either COC1502 or COC1503,150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates.
Cancer of the endometrium, 75 cases (1.1mm), set 1
EMC1501
Pantomics 1
Description: Endometrial cancer tissue array, set 1, non-overlapping with EMC1502, 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates.
Cancer of the esophagus, 75 cases (1.1mm), set 1
ESC1501
Pantomics 1
Description: Esophagus cancer tissue array, set 1, non-overlapping with ESC1502, 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates.
Cancer of the kidney, 75 cases (1.1mm), set 1
KIC1501
Pantomics 1
Description: Kidney cancer tissue array, set 1, non-overlapping with KIC1502 or KIC1503, 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates.
Cancer of the ovary, 75 cases (1.1mm), set 1
OVC1501
Pantomics 1
Description: Ovary cancer tissue array, set 1, non-overlapping with OVC1502, 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates
Cancer of the liver, 75 cases (1.1mm), set 1
LVC1501
Pantomics 1
Description: Liver cancer tissue array, set 1, non-overlapping with LVC1502 or LVC1503, 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates
Cancer of the thyroid, 75 cases (1.1mm), set 1
THC1501
Pantomics 1
Description: Thyroid cancer tissue array, 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates
Cancer of the stomach, 75 cases (1.1mm), set 1
STC1501
Pantomics 1
Description: Stomach cancer tissue array, set 1, non-overlapping with STC1502 or STC1503, 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates
Cancer of the rectum, 75 cases (1.1mm), set 1
REC1501
Pantomics 1
Description: Rectum cancer tissue array, set 1, non-overlapping with REC1502 or REC1503, 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data.) tissues in duplicates
Cancer of the lung paired with normal, 16 cases (2mm), set 2
LUC482
Pantomics 1
Description: Lung cancer tissue array, set 2, 16 cases, 48 cores, non-over lapping with LUC481 or LUC483, one normal lung tissue core paired with two tumor tissue cores from each patient with grading and TNM staging data.
Cancer of the lung paired with normal, 16 cases (2mm), set 3
LUC483
Pantomics 1
Description: Lung cancer tissue array, set 3, 16 cases, 48 cores, non-over lapping with LUC481 or LUC482, one normal lung tissue core paired with two tumor tissue cores from each patient with grading and TNM staging data.
Cancer of the lung with progressive changes, 48 cases (1.5mm), set 2
LUC962
Pantomics 1
Description: Lung cancer tissue array, set 2, non-overlapping with LUC961, 96 cores, 48 cases from normal, premalignant and cancer tissues with progressive grades and TNM stages in duplicates.
Cancer of the bladder, 75 cases (1.1mm)
BLC1501
Pantomics 1
Description: Bladder cancer tissue array, 150 cores from normal, inflammatory (5 cases) and cancer (70 cases) tissues in duplicates, with grading and TNM staging data.
Cancer metastasis, 75 cases, >10 sites (1.1mm)
MET1501
Pantomics 1
Description: Metastatic cancer tissue array, including 75 cases of metastatic cancers from >10 anatomic sites/organs in duplicates.
Cancer of the cervix, 75 cases (1.1mm), set 2
CXC1502
Pantomics 1
Description: Cervical cancer tissue array, set 2, non-overlapping with CXC1501 or CXC1503, consisting of 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates.
Cancer of the cervix, 75 cases (1.1mm), set 3
CXC1503
Pantomics 1
Description: Cervical cancer tissue array, set 3,, non-overlapping with CXC1501 or CXC1502, consisting of 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates.
Cancer of the breast, 75 cases (1.1mm), set 10
BRC15010
Pantomics 1
Description: Breast cancer tissue array, set 10, non-overlapping with BRC1501 to BRC1509 or BRC15011 to BRC15011 or BRC1503,150 cores from normal/benign (5 cases) and cancer (70 cases) tissues in duplicates with grading, TNM staging data, AR, ER, PR, HER2, P53, EGFR, Ki67 IHC data.
Cancer of the breast, 75 cases (1.1mm), set 11
BRC15011
Pantomics 1
Description: Breast cancer tissue array, set 11, non-overlapping with BRC1501 to BRC15010,150 cores from normal/benign (5 cases) and cancer (70 cases) tissues in duplicates with grading, TNM staging data, AR, ER, PR, HER2, P53, EGFR, Ki67 IHC data.
Cancer of the breast, 75 cases (1.1mm), set 12
BRC15012
Pantomics 1
Description: Breast cancer tissue array, set 12, non-overlapping with BRC1501 to BRC15011, 150 cores from normal/benign (5 cases) and cancer (70 cases) tissues in duplicates with grading, TNM staging data, AR, ER, PR, HER2, P53, EGFR, Ki67 IHC data.
Cancer of the breast, 75 cases (1.1mm), set 2
BRC1502
Pantomics 1
Description: Breast cancer tissue array, set 2, non-overlapping with BRC1501, BRC1503 to BRC15011, 150 cores from normal/benign (5 cases) and cancer (70 cases) tissues in duplicates with grading, TNM staging, and AR, ER, PR, HER2, P53, EGFR, Ki67 IHC data.
Cancer of the breast, 75 cases (1.1mm), set 3
BRC1503
Pantomics 1
Description: Breast cancer tissue array, set 3, non-overlapping with BRC1501, BRC1502, BRC1504 to BRC15011,150 cores from normal/benign (5 cases) and cancer (70 cases) tissues in duplicates with grading, TNM staging data, AR, ER, PR, HER2, P53, EGFR, Ki67 IHC data.
Cancer of the breast, 75 cases (1.1mm), set 4
BRC1504
Pantomics 1
Description: Breast cancer tissue array, set 4, non-overlapping withBRC1501, BRC1502, BRC1503, BRC1505 to BRC15011,150 cores from normal/benign (5 cases) and cancer (70 cases) tissues in duplicates with grading, TNM staging data, AR, ER, PR, HER2, P53, EGFR, Ki67 IHC data.
Cancer of the breast, 75 cases (1.1mm), set 5
BRC1505
Pantomics 1
Description: Breast cancer tissue array, set 5, non-overlapping with BRC1501 to BRC1504 or BRC1506 to BRC15011,150 cores from normal/benign (5 cases) and cancer (70 cases) tissues in duplicates with grading, TNM staging data, ER, PR, HER2, P53, EGFR, Ki67 IHC data.
Cancer of the breast, 75 cases (1.1mm), set 6
BRC1506
Pantomics 1
Description: Breast cancer tissue array, set 6, non-overlapping with BRC1501 to BRC1505 or BRC1507 to BRC15011,150 cores from normal/benign (5 cases) and cancer (70 cases) tissues in duplicates with grading, TNM staging data, AR, ER, PR, HER2, P53, EGFR, Ki67 IHC data.
Cancer of the breast, 75 cases (1.1mm), set 7
BRC1507
Pantomics 1
Description: Breast cancer tissue array, set 7, non-overlapping with BRC1501 to BRC1506 or BRC1508 to BRC15011,150 cores from normal/benign (5 cases) and cancer (70 cases) tissues in duplicates with grading, TNM staging data, AR, ER, PR, HER2, P53, EGFR, Ki67 IHC data.
Cancer of the breast, 75 cases (1.1mm), set 8
BRC1508
Pantomics 1
Description: Breast cancer tissue array, set 8, non-overlapping with BRC1501 to BRC1507 or BRC1509 to BRC15011,150 cores from normal/benign (5 cases) and cancer (70 cases) tissues in duplicates with grading, TNM staging data, AR, ER, PR, HER2, P53, EGFR, Ki67 IHC data.
Cancer of the breast, 75 cases (1.1mm), set 9
BRC1509
Pantomics 1
Description: Breast cancer tissue array, set 9, non-overlapping with BRC1501 to BRC1508 or BRC15010 to BRC15011,150 cores from normal/benign (5 cases) and cancer (70 cases) tissues in duplicates with grading, TNM staging data, AR, ER, PR, HER2, P53, EGFR, Ki67 IHC data.
Cancer of the colon, 75 cases (1.1mm), set 2
COC1502
Pantomics 1
Description: Colon cancer tissue array, set 2, non-overlapping with either COC1501 or COC1503,150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates .
Cancer of the colon, 75 cases (1.1mm), set 3
COC1503
Pantomics 1
Description: Colon cancer tissue array, set 3, non-overlapping with either COC1501 or COC1502,150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates.
Cancer of the endometrium, 75 cases (1.1mm), set 2
EMC1502
Pantomics 1
Description: Endometrial cancer tissue array, set 2, non-overlapping with EMC1501, 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates.
Cancer of the esophagus, 75 cases (1.1mm), set 2
ESC1502
Pantomics 1
Description: Esophagus cancer tissue array, set 2, non-overlapping with ESC1501, 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates.
Cancer of the kidney, 75 cases (1.1mm), set 2
KIC1502
Pantomics 1
Description: Kidney cancer tissue array, set 2, non-overlapping with KIC1501 or KIC1503,, 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates.
Cancer of the kidney, 75 cases (1.1mm), set 3
KIC1503
Pantomics 1
Description: Kidney cancer tissue array, set 3, non-overlapping with KIC1501 or KIC1502, containing 75 cases in 150 cores with tumor paired with normal tissues from the same patients with grading and TNM staging data.
Cancer of the ovary, 75 cases (1.1mm), set 2
OVC1502
Pantomics 1
Description: Ovary cancer tissue array, set 2, non-overlapping with OVC1501, 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates
Cancer of the liver, 75 cases (1.1mm), set 2
LVC1502
Pantomics 1
Description: Liver cancer tissue array, set 2, non-overlapping with LVC1501 or LVC1503, 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates
Cancer of the liver, 75 cases (1.1mm), set 3
LVC1503
Pantomics 1
Description: Liver cancer tissue array, set 3, non-overlapping with LVC1501 or LVC1502, 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates
Cancer of the stomach, 75 cases (1.1mm), set 2
STC1502
Pantomics 1
Description: Stomach cancer tissue array, set 2, non-overlapping with STC1501 or STC1503, 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates
Cancer of the stomach, 75 cases (1.1mm), set 3
STC1503
Pantomics 1
Description: Stomach cancer tissue array, set 3, non-overlapping with STC1501 or STC1502, 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates
Cancer of the rectum, 75 cases (1.1mm), set 2
REC1502
Pantomics 1
Description: Rectum cancer tissue array, set 2, non-overlapping with REC1501 or REC1503, 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates
Cancer of the rectum, 75 cases (1.1mm), set 3
REC1503
Pantomics 1
Description: Rectum cancer tissue array, set 3, non-overlapping with REC1501 or REC1502, 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data.) tissues in duplicates
Lung Cancer Exosome
P141-LG
101Bio -
Small-cell lung cancer (HCH07) , DNA Aptamer, Biotinylated
AD-142-B
Alpha Diagnostics Custom
Small-cell lung cancer (HCH07) , DNA Aptamer, unlabeled
AD-142-U
Alpha Diagnostics Custom
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNUB0329-100
Biotium 100uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), Concentration: 0.2mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNUB0329-500
Biotium 500uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), Concentration: 0.2mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNUM0329-50
Biotium 50uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), 1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNC040329-100
Biotium 100uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), CF405S conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNC040329-500
Biotium 500uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), CF405S conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNC610329-100
Biotium 100uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), CF660R conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNC610329-500
Biotium 500uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), CF660R conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNC470329-100
Biotium 100uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), CF647 conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNC470329-500
Biotium 500uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), CF647 conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNC550329-100
Biotium 100uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), CF555 conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNC550329-500
Biotium 500uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), CF555 conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNC050329-100
Biotium 100uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), CF405M conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNC050329-500
Biotium 500uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), CF405M conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNC400329-100
Biotium 100uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), CF640R conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNC400329-500
Biotium 500uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), CF640R conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNC430329-100
Biotium 100uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), CF543 conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNC430329-500
Biotium 500uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), CF543 conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNC800329-100
Biotium 100uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), CF680 conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNC800329-500
Biotium 500uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), CF680 conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNC810329-100
Biotium 100uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), CF680R conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNC810329-500
Biotium 500uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), CF680R conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNCP0329-250
Biotium 250uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), PerCP conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNCR0329-250
Biotium 250uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), RPE conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNCA0329-250
Biotium 250uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), APC conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNCAP0329-100
Biotium 100uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNCAP0329-500
Biotium 500uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNCH0329-100
Biotium 100uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNCH0329-500
Biotium 500uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNC940329-100
Biotium 100uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), CF594 conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNC940329-500
Biotium 500uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), CF594 conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNC700329-100
Biotium 100uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), CF770 conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNC700329-500
Biotium 500uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), CF770 conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNCB0329-100
Biotium 100uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), Biotin conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNCB0329-500
Biotium 500uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), Biotin conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNC880329-100
Biotium 100uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), CF488A conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNC880329-500
Biotium 500uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), CF488A conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNC680329-100
Biotium 100uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), CF568 conjugate, Concentration: 0.1mg/mL
Small Cell Lung Cancer (SCLC)(MOC-52) Antibody
BNC680329-500
Biotium 500uL
Description: Primary antibody against Small Cell Lung Cancer (SCLC)(MOC-52), CF568 conjugate, Concentration: 0.1mg/mL
Lung Tumor Tissue Array - 16 cases covering all the common types of lung cancer paired with adjacent normal tissues
Z7020065
Biochain 5 slides
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.
Lung Tumor Tissue Array - 16 cases covering all the common types of lung cancer paired with adjacent normal tissues
Z7020069
Biochain 5 slides
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.
Lung Tumor Tissue Array - Duplicated 70 cases covering all the common types of lung cancer and 5 cases of normal and oth
Z7020062
Biochain 5 slides
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.
Lung Tumor Tissue Array - Duplicated 70 cases covering all the common types of lung cancer and 5 cases of normal and oth
Z7020063
Biochain 5 slides
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Did not find what you were looking for? Send us request and we will contact with you!